´ëÇÑ°¡Àӷº¸Á¸ÇÐȸ Á¦20Â÷ Çмú´ëȸ ¹× ¿¬¼ö°ÁÂ(¿ÀÇÁ¶óÀÎ) : 2023-12-03
±³À°ÀÏÀÚ : 2023-12-03
±³À°Àå¼Ò : ÆDZ³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç
±³À°ÁÖÁ¦ : ´ëÇÑ°¡Àӷº¸Á¸ÇÐȸ Á¦20Â÷ Çмú´ëȸ ¹× ¿¬¼ö°ÁÂ(¿ÀÇÁ¶óÀÎ)
ÁÖÃÖ±â°ü : ´ëÇÑ»êºÎÀΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ°¡Àӷº¸Á¸ÇÐȸ
´ã´çÀÚ : À̺¸¶ó
¿¬¶ôó : 031-738-0369
À̸ÞÀÏ : ksfp2013@gmail.com
±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀÎ : 130¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í ¿ÀÇÁ¶óÀÎ 5¸¸¿ø(Àü¹®ÀÇ),3¸¸¿ø(Àü°øÀÇ)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 08:20~08:55 µî·Ï ()
±âŸ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 08:55~09:00 °³È¸»ç ÀÌÅÃÈÄ(´ëÇÑ°¡Àӷº¸Á¸ÇÐȸ ȸÀå)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 09:00~09:20 Overview (Indication, Success rate etc.) ÀÌÀçÈÆ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 09:20~09:40 Procedures of ovarian tissue cryopreservation and transplantation ÀÌ´Ù¿ë(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 09:40~10:00 Vitrification vs. slow-freezing ÀÌÀç¿Õ(À»Áö´ëÇб³)
Åä·Ð 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 10:00~10:10 Discussion ()
ÈÞ½Ä 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 10:10~10:30 Coffee Break ()
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 10:30~11:05 Restoration of Ovarian Function: Basic and Clinical Research ÀÌÁ¤·Ä(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 11:05~11:40 Therapeutic potential of placenta-derived mesenchymal stem cells on reproductive medicine ±è±âÁø(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 11:40~12:10 HP-hMG for ovarian stimulation ±èÁöÇâ(Â÷ÀÇ°úÇдë)
ÈÞ½Ä 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 12:10~13:00 Lunch ()
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 13:00~13:10 Risk factors of menopause after allogeneic hematopoietic cell transplantation in premenopausal adult women ±èÁ¤¼÷(¿ï»êÀÇ´ë)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 13:10~13:20 Injectable Artificial Ovary for Cell-based Hormone Therapy Mimicking Ovarian Follicle Structure Reduces Menopause-related Symptoms ¾çÈñ¼±(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 13:20~13:30 Effect of Vasopressin Injection Technique in Laparoscopic Excision of Unilateral Ovarian Endometriomas on Ovarian Reserve ¹èÁö¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 13:30~13:40 Comparison of fingerstick and venipuncture for AMH in Korea population Á¶¼ö¹Î(°í·ÁÀÇ´ë)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 13:40~13:50 The analysis of AMH in young women with endometriosis ÀÌÁÖÇý(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 13:50~14:10 Checkpoint inhibitor immunotherapy and ovarian reserve ±èÁ¤¼÷(¿ï»êÀÇ´ë)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 14:10~14:30 Optimal COS protocols for fertility preservation ÀÌÇöÁÖ(ºÎ»êÀÇ´ë)
Åä·Ð 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 14:30~14:40 Discussion ()
ÈÞ½Ä 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 14:40~15:00 Coffee Break ()
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 15:00~15:20 Á¤ÀÚµ¿°áº¸Á¸ - ±¹Á¦ µ¿Çâ°ú À±¸®Àû ¹®Á¦ ÀÌÀÏÇÐ(¿¬¼¼ÀÇ´ë ÀÇ·áÀ±¸®Çаú)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 15:20~15:40 ³ÀÚµ¿°áº¸Á¸ - ±¹Á¦ µ¿Çâ°ú À±¸®Àû ¹®Á¦ ÀÌÇö¾Æ(±¹°¡»ý¸íÀ±¸®Á¤Ã¥¿ø)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 15:40~16:00 ÀúÃâ»ê½Ã´ë ¸ðÀÚº¸°Ç »ç¾÷ ÃßÁø¹æÇâ ÃÖ¿µÁØ(º¸°Çº¹ÁöºÎ Ãâ»êÁ¤Ã¥°ú)
Åä·Ð 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 16:00~16:10 Discussion ()
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 16:10~16:30 FP in Keinefelter syndrome ·ù±âÁø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 16:30~16:50 Genetic causes of POI in adolescents and fertility preservation ¹Ú¼Ò¿¬(ÀÌÈÀÇ´ë)
Åä·Ð 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 16:50~17:00 Discussion ()
±âŸ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 17:00~17:10 ½Ã»ó½Ä ()
±âŸ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 17:10~17:20 Æóȸ»ç ()
±âŸ 12¿ù 03ÀÏ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º ´ë°´ç 17:20~17:25 ÃÑȸ ()